Generate Biomedicines (GENB) Analyst & Key Data

Analyst Consensus

Buy3 analysts

Buy

Updated Sep 12, 2026

Total Analysts3

Buy

2

Ratings

Updated Sep 12, 2026

Overall Rating

C-

DCF Score1.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$15.72

Median Target+63.30%

$25.67

Potential upside vs current price

Current Stock Price

$15.72

Median Target+63.30%

$25.67

Potential upside vs current price

Analyst Consensus

Buy3 analysts

Buy

Updated Sep 12, 2026

Total Analysts3

Buy

2

Ratings

Updated Sep 12, 2026

Overall Rating

C-

DCF Score1.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$15.72

Median Target+63.30%

$25.67

Potential upside vs current price

Current Stock Price

$15.72

Median Target+63.30%

$25.67

Potential upside vs current price

Generate Biomedicines, Inc.